Form 8-K - Current report:
SEC Accession No. 0001559053-25-000025
Filing Date
2025-05-16
Accepted
2025-05-16 16:05:21
Documents
14
Period of Report
2025-05-13
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K prta-20250513.htm   iXBRL 8-K 54437
2 EX-10.1 a2025mayxex101prtaxsixtham.htm EX-10.1 5838
  Complete submission text file 0001559053-25-000025.txt   194654

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT prta-20250513.xsd EX-101.SCH 1798
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT prta-20250513_lab.xml EX-101.LAB 23251
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT prta-20250513_pre.xml EX-101.PRE 13538
16 EXTRACTED XBRL INSTANCE DOCUMENT prta-20250513_htm.xml XML 2932
Mailing Address 77 SIR JOHN ROGERSON'S QUAY, BLOCK C GRAND CANAL DOCKLANDS DUBLIN 2 L2 D02 VK60
Business Address 77 SIR JOHN ROGERSON'S QUAY, BLOCK C GRAND CANAL DOCKLANDS DUBLIN 2 L2 D02 VK60 011-353-1-236-2500
PROTHENA CORP PUBLIC LTD CO (Filer) CIK: 0001559053 (see all company filings)

EIN.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35676 | Film No.: 25959047
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)